Histone deacetylation has been shown to downregulate Bcl-6 activity, and TSA treatment can accumulate inactive acetylated Bcl-6, thus leading to cell cycle arrest and apoptosis of B-cell lymphoma cells 194. The gene discussed is BCL6; the disease is B-cell non-Hodgkin lymphoma.